The Interaction of the Endocannabinoid Anandamide and Paracannabinoid Lysophosphatidylinositol during Cell Death Induction in Human Breast Cancer Cells

The Interaction of the Endocannabinoid Anandamide and Paracannabinoid Lysophosphatidylinositol during Cell Death Induction in Human Breast Cancer Cells

Endocannabinoid anandamide (AEA) and paracannabinoid lysophosphatidylinositol (LPI) play a significant role in cancer cell proliferation regulation. While anandamide inhibits the proliferation of cancer cells, LPI is known as a cancer stimulant. Despite the known endocannabinoid receptor crosstalk a...

Full description

Bibliographic Details
Main Authors:	Mikhail G. Akimov, Natalia M. Gretskaya, Evgenia I. Gorbacheva, Nisreen Khadour, Valeria S. Chernavskaya, Galina D. Sherstyanykh, Tatiana F. Kovaleko, Elena V. Fomina-Ageeva, Vladimir V. Bezuglov
Format:	Article
Language:	English
Published:	MDPI AG 2024-02-01
Series:	International Journal of Molecular Sciences
Subjects:	CB1 CB2 GPR18 TRPV1 LPI anandamide
Online Access:	https://www.mdpi.com/1422-0067/25/4/2271

Similar Items

Dual effect of anandamide on spinal nociceptive transmission in control and inflammatory conditions
by: Monica Pontearso, et al.
Published: (2024-04-01)

Glucagon-like peptide-1 excites firing and increases GABAergic miniature postsynaptic currents (mPSCs) in gonadotropin-releasing hormone (GnRH) neurons of the male mice via activation of nitric oxide (NO) and suppression of endocannabinoid signaling pathways
by: Imre Farkas, et al.
Published: (2016-09-01)

The Mechanisms of GPR55 Receptor Functional Selectivity during Apoptosis and Proliferation Regulation in Cancer Cells
by: Mikhail G. Akimov, et al.
Published: (2023-03-01)

Inhibition of synaptic transmission by anandamide precursor 20:4-NAPE is mediated by TRPV1 receptors under inflammatory conditions
by: Diana Spicarova, et al.
Published: (2023-06-01)

Irritable Bowel Syndrome: Manipulating the Endocannabinoid System as First-Line Treatment
by: Viola Brugnatelli, et al.
Published: (2020-04-01)

Dual mechanism of TRKB activation by anandamide through CB1 and TRPV1 receptors
by: Cassiano R.A.F. Diniz, et al.
Published: (2019-02-01)

CannabinEYEds: The Endocannabinoid System as a Regulator of the Ocular Surface Nociception, Inflammatory Response, Neovascularization and Wound Healing
by: Francesco Aiello, et al.
Published: (2020-12-01)

Co-administration of cannabidiol and capsazepine reduces L-DOPA-induced dyskinesia in mice: Possible mechanism of action
by: Maurício dos-Santos-Pereira, et al.
Published: (2016-10-01)

TRPV1 and Endocannabinoids: Emerging Molecular Signals that Modulate Mammalian Vision
by: Daniel A. Ryskamp, et al.
Published: (2014-09-01)

Cannabinoid receptors in the inflammatory cells of canine atopic dermatitis
by: Roberto Chiocchetti, et al.
Published: (2022-09-01)

Lysophosphatidylinositol Promotes Chemotaxis and Cytokine Synthesis in Mast Cells with Differential Participation of GPR55 and CB2 Receptors
by: Lizbeth Magnolia Martínez-Aguilar, et al.
Published: (2023-03-01)

Effects of Environmental Heat Load on Endocannabinoid System Components in Adipose Tissue of High Yielding Dairy Cows
by: Gitit Kra, et al.
Published: (2022-03-01)

The Endocannabinoid System and Invertebrate Neurodevelopment and Regeneration
by: Tristyn L. Clarke, et al.
Published: (2021-02-01)

Chronic Administration of Cannabinoid Receptor 2 Agonist (JWH-133) Increases Ectopic Ovarian Tumor Growth and Endocannabinoids (Anandamide and 2-Arachidonoyl Glycerol) Levels in Immunocompromised SCID Female Mice
by: Henry L. Blanton, et al.
Published: (2022-02-01)

Endocannabinoid system and periodontitis: mechanisms and therapeutic implications
by: Lélio Fernando Ferreira SOARES, et al.
Published: (2023-12-01)

The Endocannabinoid System and Physical Exercise
by: Daniela Matei, et al.
Published: (2023-01-01)

Cannabinoids, their cellular receptors, and effects on the invasive phenotype of carcinoma and metastasis
by: Judah Glogauer, et al.
Published: (2022-02-01)

A Guide to Targeting the Endocannabinoid System in Drug Design
by: Adam Stasiulewicz, et al.
Published: (2020-04-01)

Possible Receptor Mechanisms Underlying Cannabidiol Effects on Addictive-like Behaviors in Experimental Animals
by: Ewa Galaj, et al.
Published: (2020-12-01)

The Endocannabinoid System as a Potential Mechanism through which Exercise Influences Episodic Memory Function
by: Paul D. Loprinzi, et al.
Published: (2019-05-01)

Endocannabinoids in stressed humans
by: Gustav Schelling
Published: (2012-09-01)

EFECTO DE LA NEUTRALIZACIóN Y ADICIóN DE EDULCORANTE EN LAS PROPIEDADES FISICOQUíMICAS, MICROBIOLóGICAS Y SENSORIALES DEL AREQUIPE DE LECHE DE BúFALA NEUTRALIZATION AND ADDITION of SWEETENING EFFECT IN PHYSICOCHEMICAL, MICROBIOLOGICAL AND SENSORY PROPERTIES OF BUFFALO MILK AREQUIPE
by: Ricardo D Andrade P, et al.
Published: (2009-05-01)

The endocannabinoid 2-arachidonoylglycerol reduces lesion expansion and white matter damage after spinal cord injury
by: Angel Arevalo-Martin, et al.
Published: (2010-05-01)

Analysis of Endocannabinoid System in Rat Testis During the First Spermatogenetic Wave
by: Marina Migliaccio, et al.
Published: (2018-05-01)

Endocannabinoid-LTP Mediated by CB1 and TRPV1 Receptors Encodes for Limited Occurrences of Coincident Activity in Neocortex
by: Yihui Cui, et al.
Published: (2018-07-01)

Glucose concentration in culture medium affects mRNA expression of TRPV1 and CB1 receptors and changes capsaicin toxicity in PC12 cells
by: Ahmad Mohammadi-Farani, et al.
Published: (2014-09-01)

Cannabidiol as a Novel Therapeutic for Immune Modulation
by: Peyravian N, et al.
Published: (2020-08-01)

<i>Cannabis</i>: From a Plant That Modulates Feeding Behaviors toward Developing Selective Inhibitors of the Peripheral Endocannabinoid System for the Treatment of Obesity and Metabolic Syndrome
by: Shira Hirsch, et al.
Published: (2019-05-01)

Endocannabinoids in Body Weight Control
by: Henrike Horn, et al.
Published: (2018-05-01)

2-AG and anandamide enhance hippocampal long-term potentiation via suppression of inhibition
by: Fouad Lemtiri-Chlieh, et al.
Published: (2022-09-01)

The endocannabinoid system in zebrafish and its potential to study the effects of Cannabis in humans
by: Ricardo Lacava Bailone, et al.
Published: (2022-02-01)

Analysis in conditional cannabinoid 1 receptor-knockout mice reveals neuronal subpopulation-specific effects on epileptogenesis in the kindling paradigm
by: E.L. von Rüden, et al.
Published: (2015-01-01)

Cannabinoids, Endocannabinoids and Sleep
by: Andrew J. Kesner, et al.
Published: (2020-07-01)

Cannabis and Endometriosis: The Roles of the Gut Microbiota and the Endocannabinoid System
by: Toobah Farooqi, et al.
Published: (2023-11-01)

Cannabinoid and Cannabinoid-Related Receptors in the Myenteric Plexus of the Porcine Ileum
by: Andrea Toschi, et al.
Published: (2021-01-01)

Roles of the Hepatic Endocannabinoid and Apelin Systems in the Pathogenesis of Liver Fibrosis
by: Pedro Melgar-Lesmes, et al.
Published: (2019-10-01)

Evaluation of cannabinoid receptors type 1–2 in periodontitis patients
by: Atefe Ataei, et al.
Published: (2022-10-01)

Endocannabinoid System Components as Potential Biomarkers in Psychiatry
by: Francisco Navarrete, et al.
Published: (2020-04-01)

Sex differences in endocannabinoid modulation of rat CA1 dendritic neurotransmission
by: Angelica Ferraro, et al.
Published: (2020-11-01)

Cannabinoid CB1 antagonists possess antiparkinsonian efficacy only in rats with very severe nigral lesion in experimental parkinsonism
by: Emilio Fernandez-Espejo, et al.
Published: (2005-04-01)